nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—Pleural effusion—Topotecan—cervical cancer	0.0388	0.0388	CcSEcCtD
Ganciclovir—Rigors—Topotecan—cervical cancer	0.0364	0.0364	CcSEcCtD
Ganciclovir—Bone pain—Topotecan—cervical cancer	0.031	0.031	CcSEcCtD
Ganciclovir—Neuropathy—Topotecan—cervical cancer	0.0279	0.0279	CcSEcCtD
Ganciclovir—Rash maculo-papular—Topotecan—cervical cancer	0.027	0.027	CcSEcCtD
Ganciclovir—Sepsis—Topotecan—cervical cancer	0.0258	0.0258	CcSEcCtD
Ganciclovir—Ear pain—Topotecan—cervical cancer	0.0253	0.0253	CcSEcCtD
Ganciclovir—Dermatitis bullous—Topotecan—cervical cancer	0.0225	0.0225	CcSEcCtD
Ganciclovir—Cardiac arrest—Topotecan—cervical cancer	0.0205	0.0205	CcSEcCtD
Ganciclovir—Cramp muscle—Topotecan—cervical cancer	0.0194	0.0194	CcSEcCtD
Ganciclovir—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0194	0.0194	CcSEcCtD
Ganciclovir—Alanine aminotransferase increased—Topotecan—cervical cancer	0.019	0.019	CcSEcCtD
Ganciclovir—Pancytopenia—Topotecan—cervical cancer	0.0177	0.0177	CcSEcCtD
Ganciclovir—Neutropenia—Topotecan—cervical cancer	0.0174	0.0174	CcSEcCtD
Ganciclovir—Pneumonia—Topotecan—cervical cancer	0.0167	0.0167	CcSEcCtD
Ganciclovir—Infestation—Topotecan—cervical cancer	0.0166	0.0166	CcSEcCtD
Ganciclovir—Infestation NOS—Topotecan—cervical cancer	0.0166	0.0166	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Topotecan—cervical cancer	0.0163	0.0163	CcSEcCtD
Ganciclovir—Stomatitis—Topotecan—cervical cancer	0.0162	0.0162	CcSEcCtD
Ganciclovir—Sweating—Topotecan—cervical cancer	0.0159	0.0159	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Topotecan—cervical cancer	0.0157	0.0157	CcSEcCtD
Ganciclovir—Haemoglobin—Topotecan—cervical cancer	0.015	0.015	CcSEcCtD
Ganciclovir—Rhinitis—Topotecan—cervical cancer	0.0149	0.0149	CcSEcCtD
Ganciclovir—Haemorrhage—Topotecan—cervical cancer	0.0149	0.0149	CcSEcCtD
Ganciclovir—Hypoaesthesia—Topotecan—cervical cancer	0.0148	0.0148	CcSEcCtD
Ganciclovir—Pharyngitis—Topotecan—cervical cancer	0.0148	0.0148	CcSEcCtD
Ganciclovir—Angiopathy—Topotecan—cervical cancer	0.0135	0.0135	CcSEcCtD
Ganciclovir—Mediastinal disorder—Topotecan—cervical cancer	0.0134	0.0134	CcSEcCtD
Ganciclovir—Chills—Topotecan—cervical cancer	0.0134	0.0134	CcSEcCtD
Ganciclovir—Alopecia—Topotecan—cervical cancer	0.0132	0.0132	CcSEcCtD
Ganciclovir—Malnutrition—Topotecan—cervical cancer	0.013	0.013	CcSEcCtD
Ganciclovir—Back pain—Topotecan—cervical cancer	0.0126	0.0126	CcSEcCtD
Ganciclovir—Muscle spasms—Topotecan—cervical cancer	0.0125	0.0125	CcSEcCtD
Ganciclovir—Ill-defined disorder—Topotecan—cervical cancer	0.012	0.012	CcSEcCtD
Ganciclovir—Anaemia—Topotecan—cervical cancer	0.012	0.012	CcSEcCtD
Ganciclovir—Malaise—Topotecan—cervical cancer	0.0117	0.0117	CcSEcCtD
Ganciclovir—Leukopenia—Topotecan—cervical cancer	0.0116	0.0116	CcSEcCtD
Ganciclovir—Cough—Topotecan—cervical cancer	0.0113	0.0113	CcSEcCtD
Ganciclovir—Arthralgia—Topotecan—cervical cancer	0.011	0.011	CcSEcCtD
Ganciclovir—Chest pain—Topotecan—cervical cancer	0.011	0.011	CcSEcCtD
Ganciclovir—Myalgia—Topotecan—cervical cancer	0.011	0.011	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.011	0.011	CcSEcCtD
Ganciclovir—Discomfort—Topotecan—cervical cancer	0.0109	0.0109	CcSEcCtD
Ganciclovir—Anaphylactic shock—Topotecan—cervical cancer	0.0106	0.0106	CcSEcCtD
Ganciclovir—Infection—Topotecan—cervical cancer	0.0105	0.0105	CcSEcCtD
Ganciclovir—Thrombocytopenia—Topotecan—cervical cancer	0.0104	0.0104	CcSEcCtD
Ganciclovir—Skin disorder—Topotecan—cervical cancer	0.0103	0.0103	CcSEcCtD
Ganciclovir—Hyperhidrosis—Topotecan—cervical cancer	0.0102	0.0102	CcSEcCtD
Ganciclovir—Anorexia—Topotecan—cervical cancer	0.0101	0.0101	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00965	0.00965	CcSEcCtD
Ganciclovir—Paraesthesia—Topotecan—cervical cancer	0.00951	0.00951	CcSEcCtD
Ganciclovir—Dyspnoea—Topotecan—cervical cancer	0.00944	0.00944	CcSEcCtD
Ganciclovir—Dyspepsia—Topotecan—cervical cancer	0.00932	0.00932	CcSEcCtD
Ganciclovir—Decreased appetite—Topotecan—cervical cancer	0.00921	0.00921	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Topotecan—cervical cancer	0.00914	0.00914	CcSEcCtD
Ganciclovir—Fatigue—Topotecan—cervical cancer	0.00913	0.00913	CcSEcCtD
Ganciclovir—Pain—Topotecan—cervical cancer	0.00906	0.00906	CcSEcCtD
Ganciclovir—Constipation—Topotecan—cervical cancer	0.00906	0.00906	CcSEcCtD
Ganciclovir—Feeling abnormal—Topotecan—cervical cancer	0.00873	0.00873	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Topotecan—cervical cancer	0.00866	0.00866	CcSEcCtD
Ganciclovir—Urticaria—Topotecan—cervical cancer	0.00841	0.00841	CcSEcCtD
Ganciclovir—Abdominal pain—Topotecan—cervical cancer	0.00837	0.00837	CcSEcCtD
Ganciclovir—Body temperature increased—Topotecan—cervical cancer	0.00837	0.00837	CcSEcCtD
Ganciclovir—Hypersensitivity—Topotecan—cervical cancer	0.0078	0.0078	CcSEcCtD
Ganciclovir—Asthenia—Topotecan—cervical cancer	0.0076	0.0076	CcSEcCtD
Ganciclovir—Pruritus—Topotecan—cervical cancer	0.00749	0.00749	CcSEcCtD
Ganciclovir—Diarrhoea—Topotecan—cervical cancer	0.00725	0.00725	CcSEcCtD
Ganciclovir—Dizziness—Topotecan—cervical cancer	0.007	0.007	CcSEcCtD
Ganciclovir—Vomiting—Topotecan—cervical cancer	0.00673	0.00673	CcSEcCtD
Ganciclovir—Rash—Topotecan—cervical cancer	0.00668	0.00668	CcSEcCtD
Ganciclovir—Dermatitis—Topotecan—cervical cancer	0.00667	0.00667	CcSEcCtD
Ganciclovir—Headache—Topotecan—cervical cancer	0.00664	0.00664	CcSEcCtD
Ganciclovir—Nausea—Topotecan—cervical cancer	0.00629	0.00629	CcSEcCtD
